Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Vitale

Showing results (271-280 of 288) with videos related to

Pageof 29
Sort By:
Hepatology Communications|July 28, 2025
Outcome of hepatic resection for HCC in ideal and non-ideal candidatesLorenzo Lani, Laura Bucci, Valentina Santi, et al.
Hepatology (Baltimore, Md.)|June 28, 2019
Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 PatientsDaniel J Firl, Kazunari Sasaki, Vatche G Agopian, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2026
Direct Acting Antivirals Before Surgical Resection of HCV Related HCC: Impact on Tumour Pathology and OutcomesGiuseppina Brancaccio, Alessandro Vitale, Francesco Paolo Russo, et al.
Alimentary Pharmacology & Therapeutics|January 14, 2026
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter StudyElisa Pinto, Filippo Pelizzaro, Vittorio Simeon, et al.
Cancers|March 6, 2021
Surveillance as Determinant of Long-Term Survival in Non-Transplanted Hepatocellular Carcinoma PatientsFilippo Pelizzaro, Alessandro Vitale, Anna Sartori, et al.
JAMA Surgery|October 28, 2020
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver RetransplantAlfonso W Avolio, Antonio Franco, Andrea Schlegel, et al.
Liver Cancer|April 22, 2026
Comparative Efficacy of Initial Treatment Strategies in Patients with Transarterial Chemoembolisation-Unsuitable Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
Hepatology (Baltimore, Md.)|July 27, 2018
Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort StudyAlessandro Vitale, Fabio Farinati, Giulia Noaro, et al.
Journal of Hepatology|November 8, 2025
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access programChristiane Stern, Véronique Loustaud-Ratti, Cihan Yurdaydin, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 16, 2025
Minimally invasive versus open liver resection for nonmetastatic hepatocellular carcinoma staged BCLC - B and - C: an Italian multicentric analysisGianluca Cassese, Mariano C Giglio, Alessandro Vitale, et al.
Pageof 29

Showing results (271-280 of 288) with videos related to

Sort By:
Pageof 29
Hepatology Communications|July 28, 2025
Outcome of hepatic resection for HCC in ideal and non-ideal candidatesLorenzo Lani, Laura Bucci, Valentina Santi, et al.
Hepatology (Baltimore, Md.)|June 28, 2019
Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 PatientsDaniel J Firl, Kazunari Sasaki, Vatche G Agopian, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2026
Direct Acting Antivirals Before Surgical Resection of HCV Related HCC: Impact on Tumour Pathology and OutcomesGiuseppina Brancaccio, Alessandro Vitale, Francesco Paolo Russo, et al.
Alimentary Pharmacology & Therapeutics|January 14, 2026
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter StudyElisa Pinto, Filippo Pelizzaro, Vittorio Simeon, et al.
Cancers|March 6, 2021
Surveillance as Determinant of Long-Term Survival in Non-Transplanted Hepatocellular Carcinoma PatientsFilippo Pelizzaro, Alessandro Vitale, Anna Sartori, et al.
JAMA Surgery|October 28, 2020
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver RetransplantAlfonso W Avolio, Antonio Franco, Andrea Schlegel, et al.
Liver Cancer|April 22, 2026
Comparative Efficacy of Initial Treatment Strategies in Patients with Transarterial Chemoembolisation-Unsuitable Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Giulia Pieri, et al.
Hepatology (Baltimore, Md.)|July 27, 2018
Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort StudyAlessandro Vitale, Fabio Farinati, Giulia Noaro, et al.
Journal of Hepatology|November 8, 2025
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access programChristiane Stern, Véronique Loustaud-Ratti, Cihan Yurdaydin, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 16, 2025
Minimally invasive versus open liver resection for nonmetastatic hepatocellular carcinoma staged BCLC - B and - C: an Italian multicentric analysisGianluca Cassese, Mariano C Giglio, Alessandro Vitale, et al.
Pageof 29